• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环miR-765和miR-149:老年冠状动脉疾病患者潜在的非侵入性诊断生物标志物。

Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients.

作者信息

Ali Sheikh Md Sayed, Xia Ke, Li Fei, Deng Xu, Salma Umme, Deng Hai, Wei Wei Liu, Yang Tian-Lun, Peng Jun

机构信息

Department of Cardiology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha, Hunan 410078, China.

Department of Cardiology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha, Hunan 410078, China ; Center for Vascular Biology and Inflammation, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

出版信息

Biomed Res Int. 2015;2015:740301. doi: 10.1155/2015/740301. Epub 2015 Jan 15.

DOI:10.1155/2015/740301
PMID:25664324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4312568/
Abstract

The purpose of this study was to evaluate the diagnostic value of circulating miR-765 and miR-149 as noninvasive early biomarkers for geriatric coronary artery disease (CAD) patients. A total of 69 angiographically documented CAD patients including 37 stable CAD (72.9 ± 4.2 years) and 32 unstable CAD (72.03 ± 4.3 years) and 20 healthy subjects (71.7 ± 5.2 years), matched for age, sex, smoking habit, hypertension, and diabetes, were enrolled in this study. Compared with healthy subjects, circulating miR-765 levels were increased by 2.9-fold in stable CAD and 5.8-fold in unstable CAD patients, respectively, while circulating miR-149 levels were downregulated by 3.5-fold in stable CAD and 4.2-fold in unstable CAD patients, respectively. Furthermore, plasma levels of miR-765 were found to be positively correlated with ages within control, stable, and unstable groups. The ROC curves of miR-765 and miR-149 represented significant diagnostic values with an area under curve (AUC) of 0.959, 0.972 and 0.938, 0.977 in stable CAD patients and unstable CAD patients as compared with healthy subjects, respectively. Plasma levels of miR-765 and miR-149 might be used as noninvasive biomarkers for the diagnosis of CAD in geriatric people.

摘要

本研究的目的是评估循环miR - 765和miR - 149作为老年冠状动脉疾病(CAD)患者非侵入性早期生物标志物的诊断价值。本研究共纳入69例经血管造影证实的CAD患者,包括37例稳定型CAD患者(72.9±4.2岁)和32例不稳定型CAD患者(72.03±4.3岁),以及20名健康受试者(71.7±5.2岁),这些受试者在年龄、性别、吸烟习惯、高血压和糖尿病方面相匹配。与健康受试者相比,稳定型CAD患者循环miR - 765水平分别升高2.9倍,不稳定型CAD患者升高5.8倍;而稳定型CAD患者循环miR - 149水平分别下调3.5倍,不稳定型CAD患者下调4.2倍。此外,发现miR - 765的血浆水平在对照组、稳定组和不稳定组中均与年龄呈正相关。与健康受试者相比,miR - 765和miR - 149的ROC曲线在稳定型CAD患者和不稳定型CAD患者中分别具有显著的诊断价值,曲线下面积(AUC)分别为0.959、0.972和0.938、0.977。miR - 765和miR - 149的血浆水平可能用作老年人CAD诊断的非侵入性生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/4312568/41e6082a8475/BMRI2015-740301.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/4312568/a57e69aa82b5/BMRI2015-740301.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/4312568/41e6082a8475/BMRI2015-740301.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/4312568/a57e69aa82b5/BMRI2015-740301.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/4312568/41e6082a8475/BMRI2015-740301.002.jpg

相似文献

1
Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients.循环miR-765和miR-149:老年冠状动脉疾病患者潜在的非侵入性诊断生物标志物。
Biomed Res Int. 2015;2015:740301. doi: 10.1155/2015/740301. Epub 2015 Jan 15.
2
The diagnostic value of circulating microRNAs for middle-aged (40-60-year-old) coronary artery disease patients.循环微RNA对中年(40 - 60岁)冠心病患者的诊断价值。
Clinics (Sao Paulo). 2015 Apr;70(4):257-63. doi: 10.6061/clinics/2015(04)07.
3
MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.miR-423 在稳定性和不稳定性冠状动脉疾病患者中的表达差异:一项初步研究。
PLoS One. 2019 May 6;14(5):e0216363. doi: 10.1371/journal.pone.0216363. eCollection 2019.
4
Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.循环 miR-155、miR-145 和 let-7c 作为冠心病的诊断生物标志物。
Sci Rep. 2017 Feb 16;7:42916. doi: 10.1038/srep42916.
5
Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.循环 miR-133b 和 miR-21 作为冠状动脉疾病早期预测和诊断的新型生物标志物。
Genes (Basel). 2020 Feb 5;11(2):164. doi: 10.3390/genes11020164.
6
Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.脂代谢相关微小RNA在外周血单个核细胞中作为冠状动脉疾病生物标志物的潜在作用
J Atheroscler Thromb. 2017 Apr 3;24(4):430-441. doi: 10.5551/jat.35923. Epub 2016 Sep 13.
7
Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.循环微小RNA作为极早发(≤40岁)冠状动脉疾病的新型诊断生物标志物
Biomed Environ Sci. 2016 Aug;29(8):545-554. doi: 10.3967/bes2016.073.
8
Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.循环中富含内皮细胞的微小RNA-126作为2型糖尿病患者冠状动脉疾病的潜在生物标志物。
Biomarkers. 2017 May-Jun;22(3-4):268-278. doi: 10.1080/1354750X.2016.1204004. Epub 2016 Jul 11.
9
Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.循环中的miR-106a可能作为冠心病患者潜在的生物标志物。
Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.190345.
10
Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.冠心病患者中循环中Toll样受体4反应性微小RNA谱:肾素-血管紧张素系统阻滞剂治疗的前瞻性随机研究结果
Clin Sci (Lond). 2015 Apr;128(8):483-91. doi: 10.1042/CS20140417.

引用本文的文献

1
Long noncoding RNA alleviates angiotensin II-induced cardiac hypertrophy phenotypes by mediating the miR-765/Wnt family member 7B pathway.长链非编码RNA通过介导miR-765/ Wnt家族成员7B通路减轻血管紧张素II诱导的心脏肥大表型。
Open Med (Wars). 2023 May 12;18(1):20230681. doi: 10.1515/med-2023-0681. eCollection 2023.
2
Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism.冠状动脉疾病患者来源的 iPSC 肝细胞具有独特的 miRNA 谱,可能改变脂质代谢。
Sci Rep. 2023 Jan 30;13(1):1706. doi: 10.1038/s41598-023-28981-7.
3
MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application.

本文引用的文献

1
MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation.微小RNA-29b抑制新生内膜形成过程中血管平滑肌细胞的迁移和增殖。
J Cell Biochem. 2015 Apr;116(4):598-608. doi: 10.1002/jcb.25011.
2
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer.循环中的miR-483-3p和miR-21在胰腺癌患者血浆中高表达。
Int J Oncol. 2015 Feb;46(2):539-47. doi: 10.3892/ijo.2014.2743. Epub 2014 Nov 10.
3
Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
微小 RNA 作为 2 型糖尿病相关冠状动脉疾病的生物标志物:从发病机制到潜在的临床应用。
Int J Mol Sci. 2022 Dec 29;24(1):616. doi: 10.3390/ijms24010616.
4
CircRNA-miRNA interactions in atherogenesis.动脉粥样硬化发生过程中的环状RNA- microRNA相互作用
Mol Cell Biochem. 2022 Dec;477(12):2703-2733. doi: 10.1007/s11010-022-04455-8. Epub 2022 May 23.
5
Bioinformatics analysis identifies potential diagnostic signatures for coronary artery disease.生物信息学分析确定冠心病的潜在诊断标志物。
J Int Med Res. 2020 Dec;48(12):300060520979856. doi: 10.1177/0300060520979856.
6
The diagnostic value of circulating microRNAs as biomarkers for coronary artery disease: A meta‑analysis.循环 microRNAs 作为冠心病生物标志物的诊断价值:Meta 分析。
Anatol J Cardiol. 2020 Nov;24(5):290-299. doi: 10.14744/AnatolJCardiol.2020.91582.
7
rs12196996, a polymorphism at the gene flanking intron, is associated with circFOXO3 levels and the risk of coronary artery disease.rs12196996 是位于基因侧翼内含子的一个多态性,与 circFOXO3 水平和冠心病风险相关。
Aging (Albany NY). 2020 Jul 2;12(13):13076-13089. doi: 10.18632/aging.103398.
8
Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.基于直接 S-Poly(T)Plus 检测的循环 microRNA 谱用于冠心病的检测。
J Cell Mol Med. 2020 Jun;24(11):5984-5997. doi: 10.1111/jcmm.15001. Epub 2020 Apr 28.
9
MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.miR-421 通过调控 MCPIP1 的表达促进骨肉瘤的发生发展。
Cancer Biol Ther. 2020;21(3):231-240. doi: 10.1080/15384047.2019.1683331. Epub 2019 Nov 12.
10
Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.循环 microRNAs 作为冠心病诊断生物标志物的临床意义。
J Cell Mol Med. 2020 Jan;24(1):1146-1150. doi: 10.1111/jcmm.14802. Epub 2019 Nov 11.
血管炎症在冠状动脉疾病中的作用:抗炎药物在预防动脉粥样硬化血栓形成方面的潜力。冠状动脉疾病中的炎症与抗炎药物。
Am J Cardiovasc Drugs. 2015 Feb;15(1):1-11. doi: 10.1007/s40256-014-0094-z.
4
Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.肾动脉狭窄患者循环和肾静脉中微小RNA的水平
Nephrol Dial Transplant. 2015 Mar;30(3):480-90. doi: 10.1093/ndt/gfu341. Epub 2014 Oct 31.
5
TNF-α alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells.肿瘤坏死因子-α改变了内皮细胞中微粒包裹的微小RNA的释放和转移。
Physiol Genomics. 2014 Nov 15;46(22):833-40. doi: 10.1152/physiolgenomics.00079.2014. Epub 2014 Oct 14.
6
Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.高强度他汀类药物治疗后基线脂蛋白和C反应蛋白水平对冠状动脉粥样硬化消退的影响。
Am J Cardiol. 2014 Nov 15;114(10):1465-72. doi: 10.1016/j.amjcard.2014.08.009. Epub 2014 Aug 27.
7
Circulating microRNAs serve as novel biological markers for intracranial aneurysms.循环微RNA作为颅内动脉瘤的新型生物标志物。
J Am Heart Assoc. 2014 Sep 23;3(5):e000972. doi: 10.1161/JAHA.114.000972.
8
Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study.肾功能不全的非ST段抬高型心肌梗死患者冠状动脉疾病与C反应蛋白水平的关系:一项回顾性研究
BMC Nephrol. 2014 Sep 17;15:152. doi: 10.1186/1471-2369-15-152.
9
MicroRNAs as non-invasive biomarkers of heart transplant rejection.微小 RNA 作为心脏移植排斥的非侵入性生物标志物。
Eur Heart J. 2014 Dec 1;35(45):3194-202. doi: 10.1093/eurheartj/ehu346. Epub 2014 Aug 31.
10
Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs.血流敏感型微小RNA在内皮功能障碍和动脉粥样硬化中的作用:机械敏感型动脉粥样硬化微小RNA
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2206-16. doi: 10.1161/ATVBAHA.114.303425. Epub 2014 Jul 10.